Comparison of Phase I-II designs with parametric or semi-parametric models using two different risk-benefit trade-off criteria.

Comparison of Phase I-II designs with parametric or semi-parametric models using two different risk-benefit trade-off criteria. Contemp Clin Trials. 2020 10; 97:106099.

View in: PubMed

subject areas

Bayes Theorem
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Computer Simulation
Dose-Response Relationship, Drug
Humans
Research Design
Risk Assessment

authors with profiles

PETER F THALL